Risperidal Consta

DRUG2 trials

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Réseau de Santé Vitalité Health Network

Conditions

Psychotic DisordersSchizophreniaSchizophrenia Spectrum and Other Psychotic Disorders

Phase 4

Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia

CompletedNCT00299702

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Psychotic Disorders, Schizophrenia

Start: 2006-02-28End: 2009-01-31Updated: 2011-12-30

Unknown Phase

Mirror-image Study of Paliperidone Palmitate and Risperidone Long-acting Injection

Réseau de Santé Vitalité Health NetworkSchizophrenia Spectrum and Other Psychotic Disorders

Start: 2018-01-02End: 2018-12-31Target: 328Updated: 2018-01-04